Description
Sotorasib is a inhibitor of KRASG12C, which is a notoriously difficult to treat cancerous mutation.
Product Unit Size | Cost | Quantity | Stock |
---|
Sotorasib is a inhibitor of KRASG12C, which is a notoriously difficult to treat cancerous mutation.
Cas No. | 2252403-56-6 |
---|---|
Purity | ≥99% |
Formula | C30H30F2N6O3 |
Formula Wt. | 560.61 |
IUPAC Name | 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-propan-2-ylpyridin-3-yl)-4-[(2S)-2-methyl-4-prop-2-enoylpiperazin-1-yl]pyrido[2,3-d]pyrimidin-2-one |
Synonym | AMG-510 racemate |
Appearance | White powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Zheng X, Luo J, Liu W, et al. Sotorasib: a treatment for non-small cell lung cancer with the KRAS G12c mutation. Drugs Today (Barc). 2022 Apr;58(4):175-185. PMID: 35412531
Werner J, Davies R, Wahlstrom J, et al. Mercapturate pathway metabolites of sotorasib, a covalent inhibitor of KRASG12c, are associated with renal toxicity in the Sprague Dawley rat. Toxicol Appl Pharmacol. 2021 Jul 15;423:115578. PMID: 34004237
Koga T, Suda K, Fujino T, et al. KRAS secondary mutations that confer acquired resistance to KRAS G12c inhibitors, sotorasib and adagrasib, and overcoming strategies: insights from in vitro experiments. J Thorac Oncol. 2021 Aug;16(8):1321-1332. PMID: 33971321
Impurity of everolimus
SIRT2 inhibitor.
Semi-synthetic derivative of chlorophyll; food ...
V2 antagonist.
Recombinant HIV-1 glycoprotein antigen fragment...
Aldosterone antagonist.
Peptide fragment of VSV; LDLR agonist.
Inhibitor of CDK.
BHA derivative.
Piperazine; 5-HT1 agonist, 5-HT2/3 and α2-adre...
Aureothricin is a member of the dithiolopyrrolo...
Fluoroquinolone; topoisomerase IV and bacterial...
Cannabinoid receptor 2 selective agonist.
β1-adrenergic antagonist.
Polyether neurotoxin found in Karenia brevis; N...
SERT and NET inhibitor, Nav1.7 Na+ channel bloc...
Viologen derivative
R-type Ca2+ and voltage-gated Na+ channel block...
Neuropeptide hormone found in insects, involved...
ACE inhibitor.